MARATTO

preprint · F1000Research

Assessing risk perceptions that contribute to tetanus toxoid maternal vaccine hesitancy in Kilifi County, Kenya

2024Open accessPwani University

Abstract

<ns3:p>Background Vaccination is one of the most effective public health interventions today. However, a growing number of people perceive vaccines as unsafe and unnecessary. Methods We used a mixed method research in which we administered a quantitative survey to men and women of reproductive age, held Focus Group Discussions (FGDs) with expectant mothers, and interviewed Key Informants (KI) to understand maternal vaccine hesitancy within a rural setting of Kilifi County, Kenya. Results Of the 104 people surveyed, 70% of the participants were aware of the vaccine that expectant women receive, with 26% stating that they know people in their community who have refused or were hesitant to take maternal vaccination. Reasons for refusals include religion and rumours that have spread in the community that the tetanus toxoid vaccine was a family planning method. Stockout of the vaccine was identified as one of the healthcare factors affecting vaccine uptake. Healthcare workers were the most trusted source for information about maternal vaccines. Conclusion Dissemination of accurate information and continuous engagement with community members can build trust and confidence in maternal vaccines.</ns3:p>

Research topics

  • Vaccine Coverage and Hesitancy
  • Diphtheria, Corynebacterium, and Tetanus
  • Bacterial Infections and Vaccines

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.12688/f1000research.144710.1

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.